Document is current
Any future updates will be listed below
-
Authors
Kever, Anne
Buyukturkoglu, Korhan
Riley, Claire S.
De Jager, Philip L.
Leavitt, Victoria M. https://orcid.org/0000-0001-8937-6079
-
Funding
Funding for this research was provided by:
National Multiple Sclerosis Society (RG-1508- 05892, MB-1605-08706)
National Center for Medical Rehabilitation Research of the National Institute of Child Health and Development (R01 HD082176))
- License Information
-
More Information
Article History
Received: 22 June 2020
Revised: 16 November 2020
Accepted: 19 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Claire S. Riley reports consulting or advisory work with Biogen Idec, Celgene, Genentech/Roche, Genzyme, TG Therapeutics. Philip De Jager is on the advisory board for the following: Celgene, Roche, Biogen, Genzyme, and has sponsored research agreements with Roche and Biogen. Victoria M. Leavitt has received consulting fees from Healios, Inc, and is the co-founder of eSupport Health, PBC. Anne Kever and Korhan Buyukturkoglu report no disclosures.
: Ethical approval was granted by the institutional review boards of the Icahn School of Medicine at Mount Sinai and the Columbia University Irving Medical Center. All participants provided written informed consent.
